Sequella  
Sequella是一个临床阶段的公司，专注于商业化严重的传染性疾病的全身性抗感染药改进治疗方法。该公司利用其全球影响力，研发平台和传染性疾病的专业知识，积极应对出现的健康威胁。通过集中执行，清晰的商业化途径和战略合作伙伴关系，Sequella打算商业化的广泛的产品组合，可用于治疗感染性疾病的威胁显着的市场机会。

Sequella is a clinical stage antiinfectives company focused on commercializing improved treatments for serious infectious diseases. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats. Through focused execution, clear commercialization pathways, and strategic partnerships, Sequella intends to commercialize a broad product portfolio designed to treat infectious disease threats with significant market opportunity.